Company: PTHS
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001753926-25-001326
Chunk: 198

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 2
Chunk 198
---
5 and incorporated by reference herein).

    10.22

    31.1
     
    Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

    31.2
     
    Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

    32.1
     
    Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

    32.2
     
    Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

    101
     
    Interactive Data Files (embedded within the Inline XBRL document)

    104
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

+
Indicates management contract or compensatory plan. 

In
accordance with SEC Release 33-8238, Exhibit 32.1 is being furnished and not filed.

49 

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.

Date:
August 13, 2025

    Pelthos
    Therapeutics Inc.

    By:
    /s/
    Scott Plesha

    Name:
    Scott Plesha

    Title:
    Chief Executive Officer and President (Principal Executive Officer)

    By:
    /s/
    Francis Knuettel II

    Name:
    Francis Knuettel II

    Title:
                                   Chief Financial Officer, Treasurer and Secretary 
        
        (Principal
Financial Officer, Principal Accounting Officer) 

50